- Home
- UHT
as 10-28-2025 2:03am EST
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
| Founded: | 1986 | Country: | United States |
| Employees: | N/A | City: | KING OF PRUSSIA |
| Market Cap: | 515.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 75.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.30 | EPS Growth: | -0.85 |
| 52 Week Low/High: | $34.56 - $43.38 | Next Earning Date: | 10-27-2025 |
| Revenue: | $100,639,000 | Revenue Growth: | 0.74% |
| Revenue Growth (this year): | -0.1% | Revenue Growth (next year): | 0.81% |
Latest Universal Health Realty Income Trust News
UHT Breaking Stock News: Dive into UHT Ticker-Specific Updates for Smart Investing
Insider Monkey
a month ago
Why Universal Health Realty Income Trust (UHT) Stands Out Among REIT Dividend Stocks
Insider Monkey
4 months ago
Here’s What You Should Know about UHT’s Dividend
Argus Research
4 months ago
UHT: What does Argus have to say about UHT?
PR Newswire
5 months ago
UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND INCREASE
Argus Research
5 months ago
UHT: Raising target price to $45.00
Zacks
5 months ago
UHT Downgraded to Neutral Amid Leasing & Rate Pressures
Argus Research
5 months ago
UHT: What does Argus have to say about UHT?
Argus Research
6 months ago
UHT: Raising target price to $43.00
Compare UHT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "UHT Universal Health Realty Income Trust - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.